Cargando…
Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403698/ https://www.ncbi.nlm.nih.gov/pubmed/32508054 http://dx.doi.org/10.1002/ctm2.92 |
| _version_ | 1783566993595564032 |
|---|---|
| author | Li, Anlin Chen, Yongjian Zhang, Wenda Zhong, Haitao Ou, Qiyun Gu, Yang Xia, Junqing Lin, Dagui Fu, Tuping Liu, Ruixin Hu, Hai Yu, Yunfang Yao, Herui |
| author_facet | Li, Anlin Chen, Yongjian Zhang, Wenda Zhong, Haitao Ou, Qiyun Gu, Yang Xia, Junqing Lin, Dagui Fu, Tuping Liu, Ruixin Hu, Hai Yu, Yunfang Yao, Herui |
| author_sort | Li, Anlin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7403698 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74036982020-08-06 Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers Li, Anlin Chen, Yongjian Zhang, Wenda Zhong, Haitao Ou, Qiyun Gu, Yang Xia, Junqing Lin, Dagui Fu, Tuping Liu, Ruixin Hu, Hai Yu, Yunfang Yao, Herui Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2020-06-05 /pmc/articles/PMC7403698/ /pubmed/32508054 http://dx.doi.org/10.1002/ctm2.92 Text en © 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letter to Editor Li, Anlin Chen, Yongjian Zhang, Wenda Zhong, Haitao Ou, Qiyun Gu, Yang Xia, Junqing Lin, Dagui Fu, Tuping Liu, Ruixin Hu, Hai Yu, Yunfang Yao, Herui Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers |
| title | Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers |
| title_full | Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers |
| title_fullStr | Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers |
| title_full_unstemmed | Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers |
| title_short | Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers |
| title_sort | joint association of patients’ sex and pd‐l1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403698/ https://www.ncbi.nlm.nih.gov/pubmed/32508054 http://dx.doi.org/10.1002/ctm2.92 |
| work_keys_str_mv | AT lianlin jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers AT chenyongjian jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers AT zhangwenda jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers AT zhonghaitao jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers AT ouqiyun jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers AT guyang jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers AT xiajunqing jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers AT lindagui jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers AT futuping jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers AT liuruixin jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers AT huhai jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers AT yuyunfang jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers AT yaoherui jointassociationofpatientssexandpdl1expressionwithoverallsurvivalbenefitsandtumorimmunemicroenvironmentinimmunecheckpointinhibitorsforcancers |